https://www.avient.com/sites/default/files/2020-09/advanced-dispersions-color-selection-chart-1.pdf
PR 202
ADVANCED DISPERSIONS
SPECIALTY COLORANTS
Spectrophotometric
Fact Sheet
EXPLANATION OF SPECTROPHOTOMETRIC DATA
Avient certifies our colorants based on CIELAB
spectrophotometric color difference data for each
lot of product.
https://www.avient.com/sites/default/files/2021-04/additives-listing.pdf
IV BUILDERS FOR SHEET EXTRUSION
Challenge: Melt viscosity is negatively impacted by
multiple heat cycles.
https://www.avient.com/sites/default/files/2024-03/Terms and Conditions of Sale for South Africa.pdf
Seller warrants good and clear title in
goods subject to the sale (“Product”) and that the Product conforms
at the time of shipment to a Certificate of Analysis, a Certificate of
Compliance, or a Product Specification Sheet, if any such document
exists, and other specifications signed by Seller (“Specifications”).
Buyer acknowledges that information in Seller’s
marketing materials, technical data sheets and other descriptive
publications distributed or published on its websites may vary from
time to time without notice.
Buyer acknowledges that Seller has furnished to Buyer
Safety Data Sheets, which include warnings together with safety and
health information concerning the Product and/or the containers for
such Product.
https://www.avient.com/sites/default/files/2024-12/Terms and Conditions of Sale for Indonesia %28English translation%29.pdf
Seller warrants good and clear title in
goods subject to the sale (“Product”) and that the Product conforms
at the time of shipment to a Certificate of Analysis, a Certificate of
Compliance, or a Product Specification Sheet, if any such document
exists, and other specifications signed by Seller (“Specifications”).
Buyer acknowledges that information in Seller’s
marketing materials, technical data sheets and other descriptive
publications distributed or published on its websites may vary from
time to time without notice.
Buyer acknowledges that Seller has furnished to Buyer
Safety Data Sheets, which include warnings together with safety and
health information concerning the Product and/or the containers for
such Product.
https://www.avient.com/sites/default/files/2024-05/Responsible Care_14001 Global Cert_Avient_2024.pdf
Avient Corporation
Avient Corporation HQ
Certificate No: 65536
Certification Date: 29 September 2023
CORPORATE SUPPORT ACTIVITIES, DESIGN, MANUFACTURE AND DISTRIBUTION OF COLOUR AND ADDITIVE
CONCENTRATES, THERMOPLASTIC RESINS AND PELLETS, SPECIALTY COMPOUNDS AND COLORANTS.
NEU Specialty Engineered Materials, LLC
15 Corporate Drive
North Haven, CT 06473
Compound, Supply, and Prototyping Services of Thermoplastics
65536-109481Certificate No:
Page 34 of 53
ABS Quality Evaluations, Inc. 1701 City Plaza Drive, Spring, TX 77389, U.S.A.
Ezcabarte calle H Nº3
Oricain, Navarra 31194
Manufacture of Masterbatches, Additives, ECCOH, and Compounds for Pigmenting Thermoplastic
65536-116899Certificate No:
Page 36 of 53
ABS Quality Evaluations, Inc. 1701 City Plaza Drive, Spring, TX 77389, U.S.A.
https://www.avient.com/investor-center/news/future-mobility-innovations-gain-traction-visionary-polyone-materials-and-services-portfolio
ADAS: Protecting sensors and cameras from EMI/RFI interference with electrically conductive thermoplastics that reduce weight versus metal
Interior air quality: Developing thermoplastic elastomers that meet Vehicle Interior Air Quality (VIAQ) standards for HVAC components
https://www.avient.com/news/specialty-and-sustainable-healthcare-material-solutions-avient-medtec-china-2023
SUZHOU, China – June 1, 2023 – Today, Avient Corporation will exhibit its broad range of specialty and sustainable colorants and additives, thermoplastic elastomers, and high-temperature colorants for healthcare during Medtec China 2023, an annual global exhibition dedicated to the design and manufacturing of medical devices.
High-Performance Polymer Solutions for In Vitro Diagnosis (IVD) and Labware Applications, including laser welding and laser marking, customized colorants and functional additives, low retention additives, nucleating/clarifying agents, conductive black formulations, engineered polymers, and thermoplastic elastomers (TPEs.)
https://www.avient.com/news/polyone-expands-healthcare-portfolio-biomerics’-specialty-medical-solutions
CLEVELAND – PolyOne Corporation (NYSE: POL), a premier global provider of specialized polymer materials, services and solutions, today announced that Biomerics has chosen PolyOne Distribution as the exclusive distributor for its Quadrathane™, Quadraflex™, and Quadraplast™ medical-grade thermoplastic polyurethanes in North America.
Thermoplastic polyurethanes from Biomerics are used in a variety of medical device applications such as vascular access catheters, introducers, drainage catheters, interventional radiology devices, fluid management, coatings, balloons and wound care.
https://www.avient.com/sites/default/files/resources/POL%2520Credit%2520Suisse%2520IR%2520Presentation%2520w%2520non-GAAP%25209%252017%25202013.pdf
Average Debt Q2 2012 Q3 2012 Q4 2012 Q1 2013 Q2 2013 Average
PolyOne Debt $ 705.8 $ 705.2 $ 706.9 $ 1,055.5 $ 1,031.2 $ 840.9
Average Equity Q2 2012 Q3 2012 Q4 2012 Q1 2013 Q2 2013 Average
PolyOne shareholders’ equity $ 604.3 $ 629.3 $ 629.1 $ 871.8 $ 993.9 $ 745.7
Platform sales and operating income (OI) H1 2012*** H1 2013*** H1 2013****
Global Specialty Engineered Materials Sales $ 280.9 $ 352.0 $ 285.1
Global Color, Additives and Inks Sales 413.9 434.7 409.2
Designed Structures & Solutions Sales - 240.4 -
Specialty Platform Sales $ 694.8 $ 1,027.1 $694.3
Performance Products and Solutions Sales 336.0 336.7 317.5
PolyOne Distribution Sales 533.6 543.1 543.1
Corporate and Eliminations (62.3) (68.2) (68.2)
Total Sales $ 1,502.1 $ 1,838.7 $ 1,486.7
Global Specialty Engineered Materials OI $ 24.6 $ 32.5 $ 31.2
Global Color, Additives and Inks OI 44.0 54.7 52.0
Designed Structures & Solutions OI - 10.5 -
Specialty Platform OI $ 68.6 $ 97.7 $ 83.2
Performance Products and Solutions OI 19.3 27.5 25.7
PolyOne Distribution OI 33.4 33.1 33.1
Corporate and eliminations (20.3) (25.7) (20.3)
Special items in OI (20.3) (11.4) (20.3)
Operating income - GAAP $ 80.7 $ 121.2 $ 101.4
Special items in OI 20.3 11.4 20.3
Operating income adjusted $ 101.0 $ 132.6 $ 121.7
Global Specialty Engineered Materials - OI % of sales
8.8% 9.2% 10.9%
Global Color, Additives and Inks - OI % of sales 10.6% 12.6% 12.7%
Designed Structures & Solutions - OI % of sales - 4.4% -
Specialty platform - OI % of sales 9.9% 9.5% 12.0%
PP&S operating - OI % of sales 5.7% 8.2% 8.1%
Distribution OI - % of sales 6.3% 6.1% 6.1%
PolyOne OI adjusted - % of sales 6.7% 7.2% 8.2%
Reconciliation to Condensed Consolidated Balance Sheets H1 2013
Short-term debt and current portion of long-term debt $ 8.7
Long-term debt 1,022.5
Less cash and cash equivalents (392.4)
Specialty Platform Gross Margin Percentage 2006Y* Q2 2013****
Global Specialty Engineered Materials Sales $ 345.3 $ 143.5
Global Color, Additives and Inks Sales 531.8 207.5
Specialty Platform Sales $ 877.1 $ 351.0
Global Specialty Engineered Materials Gross Margin $ 41.6 $ 37.3
Global Color, Additives and Inks Gross Margin 83.6 71.8
Specialty Platform Gross Margin $ 125.2 $ 109.1
Specialty Platform Gross Margin Percentage 14.3% 31.1%
* Historical results include the Resin and Specialty Coatings businesses within the Performance Products and Solutions segment.
Credit Suisse September 2013 Investor Presentation non-GAAP v2.pdf
Reconciliation to Condensed Consolidated Balance Sheets
https://www.avient.com/sites/default/files/resources/POL%2520CFA%2520IR%2520Presentation%2520w%2520non%2520GAAP%252011%252019%25202013.pdf
Average Debt Q3 2012 Q4 2012 Q1 2013 Q2 2013 Q3 2013 Average
PolyOne Debt $ 705.2 $ 706.9 $ 1,055.5 $ 1,031.2 $ 987.7 $ 897.3
Average Equity Q3 2012 Q4 2012 Q1 2013 Q2 2013 Q3 2013 Average
PolyOne shareholders’ equity $ 629.3 $ 629.1 $ 871.8 $ 993.9 $ 996.6 $ 824.1
Reconciliation to Condensed Consolidated Balance Sheets YTD 2013
Short-term debt and current portion of long-term debt $ 9.9
Long-term debt 977.8
Less cash and cash equivalents (322.8)
Net debt $ 664.9
Adjusted EBITDA Q4 2012 Q1 2013 Q2 2013 Q3 2013 Total
PolyOne Income before income taxes $ (1.1) $ 15.7 $ 62.9 $ 38.8 $ 116.3
PolyOne Interest expense, net 13.7 15.6 16.6 16.0 61.9
PolyOne Depreciation and amortization 15.5 19.0 25.8 30.3 90.6
PolyOne Special items in EBITDA 26.5 27.7 (5.2) 11.2 60.2
PolyOne Adjusted EBITDA 54.6 78.0 100.1 96.3 329.0
Pro forma Spartech EBITDA 14.7 11.2 - - 25.9
Pro forma EBITDA $ 69.3 $ 89.2 $ 100.1 $ 96.3 $ 354.9
CFA Society Cleveland �Midwest Investment Conference 2013��PolyOne Investor Presentation �November 19, 2013�
Forward – Looking Statements
Use of Non-GAAP Measures
Strategy and Execution Drive Results
PolyOne�At A Glance
Mix Shift Highlights Specialty Transformation
Proof of Performance & 2015 Goals
Innovation Drives Earnings Growth
We are Experts in Polymer Science and Formulation
Positioned for Strong Growth
Q3 2013 Financial Highlights
Debt Maturities & Liquidity Summary – 9/30/13
Use of Cash
Why Invest In PolyOne?
ADP35C9.tmp
Reconciliation to Condensed Consolidated Balance Sheets